Biotech Archives - Page 31 of 733

2 minute read

No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms

May 15, 11:59 AM

Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines Agency about limited supplies. The company addresses high demand and reassures the availability of all doses.

LLY

2 minute read

FDA Pushes Review Date For Ascendis Pharma’s Hormone Disorder Candidate By Three Months

By Vandana Singh

May 15, 11:57 AM

Ascendis Pharma announces FDA's extension of the review date for TransCon PTH for adults with hypoparathyroidism to August 14, 2024. TransCon PTH aims to address low calcium levels due to hypoparathyroidism.

ASND

2 minute read

Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound

By Vandana Singh

May 15, 10:03 AM

Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease using Lilly branding. Corrective measures include compliance with federal law for tirzepatide products.

LLY

1 minute read

Pulmatrix Announces Peer-Reviewed Publication Headache: The Journal Of Head And Face Pain, Clinical Results For Its Orally Inhaled DHE For Acute Migraine

By Benzinga Newsdesk

May 15, 9:31 AM

Orally Inhaled PUR3100 is associated with rapid systemic PK within the therapeutic window and a mean time to Cmax matching intravenously (IV) administered DHE.Self-administered PUR3100 showed improved safety and

PULM

1 minute read

Butterfly Network Enters Bladder Scanning Market With iQ+ Bladder

By Benzinga Newsdesk

May 15, 8:35 AM

With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology.The bundled bladder solution

BFLY

1 minute read

Phathom Pharmaceuticals Will Present VOQUEZNA Data At DDW 2024 Annual Meeting, Being Held May 18-21

By Benzinga Newsdesk

May 15, 8:07 AM

First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD)1 New research on Erosive gastroesophageal reflux disease (GERD) demonstrating high

PHAT

1 minute read

On May 14, 2024, Paragon Therapeutics Announced A License Agreement Granting Spyre Therapeutics An Exclusive License To Certain Antibodies And Products Targeting α4SS7 Integrin And Tl1A, Paragon Will Up To $22M In Milestone Payments-8K

By Benzinga Newsdesk

May 15, 7:56 AM

Paragon will provide the Company with an exclusive license to its patents covering the related antibody, the method of use and its method of manufacture. Paragon will not conduct any new campaigns that generate

SYRE

1 minute read

‘Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs’ – WSJ

By Benzinga Newsdesk

May 14, 5:14 PM

https://www.wsj.com/livecoverage/stock-market-today-dow-jones-05-14-2024/card/lilly-settles-with-spa-selling-mounjaro-zepbound-knock-offs-Oy1C59kOIAqzhdhQvTve?mod=lctimeline_finance

LLY

1 minute read

Arcutis Biotherapeutics Stock Climbs After Blockbuster Q1 Results

By Erica Kollmann

May 14, 5:11 PM

Arcutis Biotherapeutics reports its first-quarter financial results after the bell Tuesday.

ARQT

1 minute read

KORU Medical Systems Signs Supply Agreement For Phase III Clinical Trial For A Novel Enzyme Replacement Therapy To Treat A Rare Endocrinological Disease

By Benzinga Newsdesk

May 14, 4:22 PM

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume

KRMD